Related Experiment Video
Updated: Aug 5, 2026

07:42
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
PACIFIC-5 Trial: Refining Patient Selection for Consolidation Durvalumab in Unresectable Stage III NSCLC
1Department of Chemoradiotherapy, Jingzhou First People's Hospital, Jingzhou, Hubei Province, China.
Thoracic Cancer
|July 26, 2026
Abstract
No abstract available in PubMed .
